Protective Role of Salidroside against Aging in A Mouse Model Induced by D-galactose

2010 ◽  
Vol 23 (2) ◽  
pp. 161-166 ◽  
Author(s):  
Gen-Xiang MAO ◽  
Hong-Bin DENG ◽  
Long-Guo YUAN ◽  
Dian-Dong LI ◽  
Yi-Yang YVONNE LI ◽  
...  
Keyword(s):  
2018 ◽  
Vol 279 ◽  
pp. 111-120 ◽  
Author(s):  
André T.R. Goes ◽  
Cristiano R. Jesse ◽  
Michelle S. Antunes ◽  
Fernando V. Lobo Ladd ◽  
Aliny A.B. Lobo Ladd ◽  
...  

2020 ◽  
Vol 92 (12) ◽  
pp. 3726-3735
Author(s):  
Li He ◽  
Qian‐qian Feng ◽  
Qiao Zhang ◽  
Bo Zhang ◽  
Si‐Si Wu ◽  
...  

2017 ◽  
Vol 152 (5) ◽  
pp. S804
Author(s):  
Li Ma ◽  
Xin Yu ◽  
Hong Lv ◽  
Hongying Wang ◽  
Jiaming QIan

Diabetes ◽  
2011 ◽  
Vol 60 (9) ◽  
pp. 2386-2396 ◽  
Author(s):  
F. Barutta ◽  
F. Piscitelli ◽  
S. Pinach ◽  
G. Bruno ◽  
R. Gambino ◽  
...  

2017 ◽  
Vol 11 (suppl_1) ◽  
pp. S118-S119
Author(s):  
L. Ma ◽  
Y. Xin ◽  
H. Lv ◽  
H. Wang ◽  
J. Qian

2000 ◽  
Vol 93 (3A) ◽  
pp. A-1333
Author(s):  
Edward T. Plata ◽  
Jadwiga D. Helinski ◽  
Bruce A. Davidson ◽  
Paul Soloway ◽  
Paul R. Knight

2018 ◽  
Vol 129 (4) ◽  
pp. 325-336 ◽  
Author(s):  
Guang Fang ◽  
Baoyan Shi ◽  
Kefeng Wu ◽  
Siyu Chen ◽  
Xiang Gao ◽  
...  

2019 ◽  
Vol 115 ◽  
pp. 108917 ◽  
Author(s):  
Xiu Yang ◽  
Daniel Thorngren ◽  
Qi Chen ◽  
Ming Wang ◽  
Xiangcheng Xie

2014 ◽  
Vol 115 (suppl_1) ◽  
Author(s):  
Fadia A Kamal ◽  
Joshua G Travers ◽  
Qing Ma ◽  
Prasad Devarajan ◽  
Burns C Blaxall

The kidneys play an important role in cardiovascular disease (CVD), where renal co-morbidities accompany CVD in a large proportion of patients thus complicating their treatment regimen. Moreover, the incidence of acute renal injury after cardiac surgery plays an important role in disease progression. Emerging data suggest the importance of understanding the mechanisms of cardio-renal injury and the development of novel therapies that can be safely used with cardiovascular and renal co-existing pathologies. Although the role of G-protein coupled receptors (GPCRs) in CVD has been broadly recognized, their role in renal injury remains poorly understood. We have found, in a chronic mouse model of heart failure, attenuated renal fibrosis and attenuated pathologic RAAS activation by the small molecule GPCR-Gβγ inhibitor “gallein”. To investigate the direct effects of GPCR-Gβγ inhibition on renal injury, we utilized an acute renal ischemia-reperfusion (RIR) mouse model. Gβγ inhibition by gallein pretreatment attenuated the histopathological profile of RIR, including attenuation of tubular hypertrophy, apoptosis, cast formation, and tissue Lipocalin2 expression. This was accompanied by attenuated inflammation, reflected by reduced CCL2 and ICAM1 gene expression and cellular infiltration, in addition to reduced Collagen III gene expression. These preliminary results suggest a promising protective role for Gβγ inhibition in renal injury and remodeling. Future mechanistic investigation of this possible protective effect will provide better understanding of the role of GPCR-Gβγ signaling in cardio-renal injury and remodeling and possible novel therapeutic targets.


Blood ◽  
2012 ◽  
Vol 120 (21) ◽  
pp. 2175-2175
Author(s):  
Masaaki Doi ◽  
Hideto Matsui ◽  
Yukiji Takeda ◽  
Yoshihiko Saito ◽  
Maiko Takeda ◽  
...  

Abstract Abstract 2175 The metalloprotease ADAMTS13 regulates the size of von Willebrand factor (VWF) multimers, controlling excessive VWF functions and preventing thrombotic occlusion of microvasculature. We previously reported that ADAMTS13 deficiency aggravated the extent of brain ischemic stroke in a mouse model of middle cerebral arterial occlusion, suggesting the relevant role of ADAMTS13 in the pathophysiology of brain stroke (Fujioka, et al. Blood, 2010; 115: 1650). These results raised the possibility that the functional regulation of VWF by ADAMTS13 could also play a role in coronary ischemic events such as myocardial infarction. To address this issue, we have used a mouse model of experimental myocardial infarction. The left anterior descending coronary artery in mice was ligated at 2 mm downstream from the origin under thoracotomy with ventilator-assisted respiration, and the cardiac function was evaluated with M-mode echocardiography after 7 days of operation. We compared 20 wild-type (WT) mice and 20 Adamts13 −/− (KO) mice, all of which were 12–14 weeks of age, healthy and fertile. Significantly (p < 0.01) decreased ejection fraction (EF; 44.0±6.7%) and increased left ventricular end-diastolic diameter (LVDd; 4.68±0.69 mm) of KO mice, as compared to WT (EF; 62.7±13.0% and LVDd; 3.77±0.56 mm, respectively), revealed that cardiac functions were apparently more impaired in KO mice. In addition, these reduced cardiac functions observed in KO mice were improved to an extent comparable to those of WT mice by the bolus injection of recombinant human ADAMTS13 (rhADAM; 3 μg/mouse, n=20) just after the operation (KO mice + rhADAM, EF; 58.2.±9.9% and LVDd; 3.16±0.52 mm). Consistent with echocardiography data, histological studies demonstrated the significantly (p < 0.01) higher infarct ratio in myocardium of KO mice (WT; 37.3±18.4%, KO; 59.1±16.3%, KO + rhADAM; 33.7±24.4%). Our results indicate that ADAMTS13, as seen in the case of brain ischemic stroke, plays a protective role for myocardium in coronary artery ischemia, improving myocardial functions and the severity of heart failure. Proper functional regulation of VWF-dependent thrombotic or inflammatory responses by ADAMTS13 could reduce thrombotic occlusion of microvasculature including leukocyte plugging, contributing to better local microcirculation which is crucial for tissue or organ functions. Disclosures: No relevant conflicts of interest to declare.


Sign in / Sign up

Export Citation Format

Share Document